371 related articles for article (PubMed ID: 28601309)
1. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
[TBL] [Abstract][Full Text] [Related]
2. Indole-3-carbinol induces tumor cell death: function follows form.
Megna BW; Carney PR; Nukaya M; Geiger P; Kennedy GD
J Surg Res; 2016 Jul; 204(1):47-54. PubMed ID: 27451867
[TBL] [Abstract][Full Text] [Related]
3. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
Chen S; Nimick M; Cridge AG; Hawkins BC; Rosengren RJ
Int J Oncol; 2018 Feb; 52(2):579-588. PubMed ID: 29207190
[TBL] [Abstract][Full Text] [Related]
4. Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.
Rajitha B; Nagaraju GP; Shaib WL; Alese OB; Snyder JP; Shoji M; Pattnaik S; Alam A; El-Rayes BF
Mol Carcinog; 2017 Jan; 56(1):288-299. PubMed ID: 27128654
[TBL] [Abstract][Full Text] [Related]
5. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer.
Bland AR; Bower RL; Nimick M; Hawkins BC; Rosengren RJ; Ashton JC
Eur J Pharmacol; 2019 Dec; 865():172749. PubMed ID: 31654622
[TBL] [Abstract][Full Text] [Related]
7. Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G; Chen ZG; Sun A; Fu H; Khuri FR; Shin DM; Snyder JP; Shoji M
Curr Cancer Drug Targets; 2014; 14(4):380-93. PubMed ID: 24628271
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative Effect of a Novel 4,4'-Disulfonyldiarylidenyl Piperidone in Human Colon Cancer Cells.
Prabhat AM; Kuppusamy ML; Bognár B; Kálai T; Hideg K; Kuppusamy P
Cell Biochem Biophys; 2019 Mar; 77(1):61-67. PubMed ID: 30552554
[TBL] [Abstract][Full Text] [Related]
9. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644
[TBL] [Abstract][Full Text] [Related]
10. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
[TBL] [Abstract][Full Text] [Related]
11. Chromatin remodeling by curcumin alters endogenous aryl hydrocarbon receptor signaling.
Mohammadi-Bardbori A; Akbarizadeh AR; Delju F; Rannug A
Chem Biol Interact; 2016 May; 252():19-27. PubMed ID: 27041069
[TBL] [Abstract][Full Text] [Related]
12. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
[TBL] [Abstract][Full Text] [Related]
13. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa.
Rinaldi AL; Morse MA; Fields HW; Rothas DA; Pei P; Rodrigo KA; Renner RJ; Mallery SR
Cancer Res; 2002 Oct; 62(19):5451-6. PubMed ID: 12359752
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer.
Rajitha B; Belalcazar A; Nagaraju GP; Shaib WL; Snyder JP; Shoji M; Pattnaik S; Alam A; El-Rayes BF
Cancer Lett; 2016 Apr; 373(2):227-33. PubMed ID: 26850372
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells.
Ronnekleiv-Kelly SM; Nukaya M; Díaz-Díaz CJ; Megna BW; Carney PR; Geiger PG; Kennedy GD
Cancer Lett; 2016 Jan; 370(1):91-9. PubMed ID: 26515162
[TBL] [Abstract][Full Text] [Related]
17. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor, a tumor grade‑associated marker of oral cancer, is directly downregulated by polydatin: A pilot study.
Martano M; Stiuso P; Facchiano A; De Maria S; Vanacore D; Restucci B; Rubini C; Caraglia M; Ravagnan G; Lo Muzio L
Oncol Rep; 2018 Sep; 40(3):1435-1442. PubMed ID: 30015848
[TBL] [Abstract][Full Text] [Related]
19. The arylhydrocarbon receptor is only marginally involved in the antileukemic effects of its ligand curcumin.
Goergens A; Frericks M; Esser C
Anticancer Res; 2009 Nov; 29(11):4657-64. PubMed ID: 20032417
[TBL] [Abstract][Full Text] [Related]
20. Mixed-ligand copper(II) complexes activate aryl hydrocarbon receptor AhR and induce CYP1A genes expression in human hepatocytes and human cell lines.
Kubešová K; Dořičáková A; Trávníček Z; Dvořák Z
Toxicol Lett; 2016 Jul; 255():24-35. PubMed ID: 27180721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
